"Cenas e coisas" que dizem que fazem bem (ou mal). Agregador de algumas notícias relacionadas com saúde. Os "disclaimers" habituais e mais alguns aplicam-se: O uso da informação aqui veiculada é por conta e risco de cada um. Consulte-se um médico ou nutricionista (conforme o caso) antes de adotar alguma medida ou informação directa ou indirectamente publicada ou veiculada.
sábado, 22 de dezembro de 2018
Cancro do Pâncreas, novo tratamento
quarta-feira, 6 de junho de 2018
Tratamento cancro pâncreas
http://www.tvi24.iol.pt/amp/tecnologia/droga/nova-quimioterapia-da-esperanca-a-doentes-com-cancro-no-pancreas
Citando:
"Dois terços dos doentes conseguiram sobreviver mais três anos com a nova terapia em relação aos que receberam os tratamentos habituais.
A nova terapia foi usada em 500 doentes, a quem foi ministrado um medicamento chamado 'folfirinox', que junta quatro substâncias usadas em quimioterapia, em testes de comparação com a terapia habitual com um medicamento denominado 'gemzar'."
domingo, 26 de março de 2017
Estudo sobre cancro pâncreas vai iniciar
Um dos cancros mais letais vai ter um estudo que quer determinar quais as melhores opções de tratamento:
http://www.bbc.com/news/uk-scotland-glasgow-west-39370595
Sobre o cancro do pâncreas (EN):
http://www.precisionpanc.org
Citando:
"A new pancreatic cancer project has been launched to find ways to speed up scientific discovery to improve the survival rates of patients.
Cancer Research have invested £10m in the PRECISION-Panc project, which aims to find quick ways of finding the right treatment for individual tumours.
Researchers at Glasgow University will receive £8m from the fund.
Prof Andrew Biankin said due to the aggressive nature of the disease, patients did not always get treatment.
"It's essential that the most suitable treatment is identified quickly," he said."
quinta-feira, 26 de janeiro de 2017
Nova combinação de drogas prolonga um pouco a esperança de vida (Cancro Pâncreas)
Citando:
"The trial showed people lived an average of 2.5 months longer if they took two drugs than if they took just one. Pancreatic cancer has a poor outlook compared with many other cancers.
Using information from the study, researchers estimated that the chances of people living for five years were 28.8% for those who took both drugs, compared with 16.3% for those treated with one drug.
However, not everyone involved in the trial was followed up for five years, so we don't know how reliable these longer-term estimates are.
The researchers say the two-drug combination should be "the new standard of care" for people who've had surgery for pancreatic cancer.
But people who took both drugs were more likely to stop treatment early because of the toxic side effects of chemotherapy.
This is an important consideration for people whose treatment can only prolong life and not achieve a cure, as there is always going to be a trade-off between survival time and quality of life."
terça-feira, 6 de setembro de 2016
Imunoterapia eficaz para cancro do pâncreas?
https://www.theguardian.com/science/2016/sep/06/new-drug-wakes-up-immune-system-to-fight-one-of-deadliest-cancers
sábado, 11 de junho de 2016
Microsoft usa dados de pesquisa para antecipar diagnóstico de Cancro Pancreático
Citando:
"The Microsoft researchers identified Web users who had recently searched for queries indicating they have pancreatic cancer, such as “I was told I have pancreatic cancer, what to expect,” and then looked back months earlier to examine patterns in the symptoms that the users searched for. This included phrases such as “dark or tarry stool,” “abdominal swelling,” “dark urine” and “yellowing skin.”
From this analysis they realized trends in the queries of users who were soon to be diagnosed with pancreatic cancer, identifying 5 to 15 percent of cases with low false-positive rates. The research was published in the Journal of Oncology Practice."
terça-feira, 1 de março de 2016
Cancro do Pâncreas - 4 subtipos identificados
Citando:
subtipo da doença: escamoso, progenitor pancreático, imunogénico ou ADEX